Pharma Journalist -

Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing a first-in-class platform of novel therapeutic compounds for the treatment of diseases…
Read More...

Biopharmaceutical company Emalex Biosciences (Emalex), the newest member of the Paragon Biosciences (Paragon) portfolio of companies, today announced it acquired Psyadon Pharmaceuticals…
Read More...

Izana Bioscience announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing spondylitis, a debilitating arthritic disease of the spine that…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair (omalizumab) for the prevention of severe allergic reactions…
Read More...

Global contract packaging organisation (CPO), Tjoapack has launched a new postponement packaging service to help customers address supply chain challenges including variable demand and…
Read More...

Cancer Prevention Pharmaceuticals announced the signing of a license agreement with Mallinckrodt Pharmaceuticals, through its Sucampo AG subsidiary, wherein Mallinckrodt obtained…
Read More...

Medicure Inc. announced that the United States Food and Drug Administration has approved its Abbreviated New Drug Application for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL)…
Read More...

TraceLink Inc., announced its Russia compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all…
Read More...

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel…
Read More...

Teneobio and Poseida Therapeutics announced a new research collaboration and licensing agreement to develop novel CAR-T therapies using Teneobio’s heavy chain only domain antibodies…
Read More...